Cargando…
A Metabolic Labeling Strategy for Relative Protein Quantification in Clostridioides difficile
Clostridioides difficile (formerly Clostridium difficile) is a Gram-positive, anaerobe, spore-forming pathogen, which causes drug-induced diseases in hospitals worldwide. A detailed analysis of the proteome may provide new targets for drug development or therapeutic strategies to combat this pathoge...
Autores principales: | Trautwein-Schult, Anke, Maaß, Sandra, Plate, Kristina, Otto, Andreas, Becher, Dörte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198727/ https://www.ncbi.nlm.nih.gov/pubmed/30386308 http://dx.doi.org/10.3389/fmicb.2018.02371 |
Ejemplares similares
-
Proteomic Signatures of Clostridium difficile Stressed with Metronidazole, Vancomycin, or Fidaxomicin
por: Maaß, Sandra, et al.
Publicado: (2018) -
Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018) -
Metabolic Reprogramming of Clostridioides difficile During the Stationary Phase With the Induction of Toxin Production
por: Hofmann, Julia D., et al.
Publicado: (2018) -
Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin
por: Maaß, Sandra, et al.
Publicado: (2021) -
What’s a Biofilm?—How the Choice of the Biofilm Model Impacts the Protein Inventory of Clostridioides difficile
por: Brauer, Madita, et al.
Publicado: (2021)